<code id='6814814FAC'></code><style id='6814814FAC'></style>
    • <acronym id='6814814FAC'></acronym>
      <center id='6814814FAC'><center id='6814814FAC'><tfoot id='6814814FAC'></tfoot></center><abbr id='6814814FAC'><dir id='6814814FAC'><tfoot id='6814814FAC'></tfoot><noframes id='6814814FAC'>

    • <optgroup id='6814814FAC'><strike id='6814814FAC'><sup id='6814814FAC'></sup></strike><code id='6814814FAC'></code></optgroup>
        1. <b id='6814814FAC'><label id='6814814FAC'><select id='6814814FAC'><dt id='6814814FAC'><span id='6814814FAC'></span></dt></select></label></b><u id='6814814FAC'></u>
          <i id='6814814FAC'><strike id='6814814FAC'><tt id='6814814FAC'><pre id='6814814FAC'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:7653
          Person wearing a blue glove holding money against a blue backdrop.
          Adobe

          WASHINGTON — Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments struck down by the Supreme Court, they announced Thursday.

          A federal court ordered the Department of Health and Human Services to compensate hospitals that receive discounted drugs through the 340B program for billions of dollars of underpayments, but the money had already gone out to hospitals that didn’t participate in the program.

          advertisement

          Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in the drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M
          Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

          CytokineticsCEORobertBlumspokelastweekatatalkduringSTAT’sBreakthroughSummitWestinSanFrancisco.SarahG

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          Digital health: a case of mistaken identity

          AdobeHistoryandliteraturearerepletewithcautionarytalesonthedangersofpretendingtobesomeone—orsomethin